(Q44551890)

English

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

scientific article published in September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza vaccine

0 references

Daniela Toneatto

6

object named as

Daniela Toneatto

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

object named as

Audino Podda

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Anna M Iorio

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Daniela Francisci

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Barbara Camilloni

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Giuliano Stagni

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Matteo De Martino

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Roberto Bugarini

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mariella Neri

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

25-26

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3629-3637

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Influenza-associated morbidity and mortality in young and middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza, influenza virus vaccine, and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of influenza vaccination on disease progression among HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune restoration with antiretroviral therapies: implications for clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of influenza vaccine (1993–1994 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900408-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(03)00408-0

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44551890&oldid=2042150438"